Article
Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine.
American journal of hematology - 1 May 2021
Morita Kiyomi, Jain Nitin, Kantarjian Hagop, Takahashi Koichi, Fang Hong, Konopleva Marina, El Hussein Siba, Wang Feng, Short Nicholas J, Maiti Abhishek, Sasaki Koji, Garcia-Manero Guillermo, Konoplev Sergej, Ravandi Farhad, Khoury Joseph D, Jabbour Elias
Abstract excerpt
Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) is characterized by a distinct immunophenotype (CD1a-negative, CD8-negative, CD5-negative or weak-positive <75%, myeloid/stem-cell markers positive) and poor clinical outcomes. Near-ETP ALL is transcriptionally similar to ETP-ALL but CD5 expression level is not low enough to meet the criteria of ETP immunophenotype. Outcomes of near-ETP...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
